l General Information |
Product Name | Terutroban |
General description | Terutroban is a highly selective and long-acting thromboxane/prostaglandin endoperoxide receptor (TPr) antagonist. |
Synonym | S18886; (6R)-6-[[(4-Chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-1-Naphthalenepropanoic acid, (R)-6-[[(4-Chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-1-Naphthalenepropanoic acid |
Purity | ≥95.0%(HPLC) | CAS Number | 165538-40-9 |
Formula | C20H22ClNO4S | Molecular Weight | 407.91 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to Beige Solid |
Solubility(25℃) | DMSO | ≥5mg/mL |
l Biological Information |
Biochem/Physiol Actions | Terutroban is a highly selective and long-acting thromboxane/prostaglandin endoperoxide receptor (TPr) antagonist. The compound Terutroban blocks thromboxane induced platelet aggregation and vasoconstriction. Terutroban prevents vascular wall proliferation and atherogenesis, increases anti-oxidant enzymes like glutathione peroxidase, and has anti-inflammatory properties. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
